

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.08378013 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.08378013 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.77137230 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.77137230 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.29622316 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22854053 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 5.68839104 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.59686675 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.59686675 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.59686675 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.45408128 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.41409368 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 5.40991814 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35862874 |
| 15 | urea metabolic process (GO:0019627) | 5.30948444 |
| 16 | urea cycle (GO:0000050) | 5.30948444 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.30093052 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.28205793 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.23069576 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 5.11256774 |
| 21 | cysteine metabolic process (GO:0006534) | 5.09930038 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.09474423 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.05698708 |
| 24 | protein carboxylation (GO:0018214) | 5.01184324 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01184324 |
| 26 | regulation of protein activation cascade (GO:2000257) | 4.91742950 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.91320511 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 4.83986088 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.79677024 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.77349318 |
| 31 | bile acid metabolic process (GO:0008206) | 4.76707336 |
| 32 | reverse cholesterol transport (GO:0043691) | 4.70436753 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67334516 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63569459 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.63569459 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.63569459 |
| 37 | phospholipid efflux (GO:0033700) | 4.61229269 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.60565677 |
| 39 | regulation of complement activation (GO:0030449) | 4.57194040 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.53810970 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.52880353 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.52880353 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.50042372 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.50042372 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.49948538 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.44726723 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.43360333 |
| 48 | ketone body metabolic process (GO:1902224) | 4.42597299 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.37711494 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.35565444 |
| 51 | cellular glucuronidation (GO:0052695) | 4.35168276 |
| 52 | lysine metabolic process (GO:0006553) | 4.19982819 |
| 53 | lysine catabolic process (GO:0006554) | 4.19982819 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 4.08002250 |
| 55 | ethanol oxidation (GO:0006069) | 4.04865294 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.03468141 |
| 57 | drug catabolic process (GO:0042737) | 4.02766496 |
| 58 | cellular response to ATP (GO:0071318) | 4.00558497 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.94470703 |
| 60 | cholesterol efflux (GO:0033344) | 3.94441944 |
| 61 | benzene-containing compound metabolic process (GO:0042537) | 3.92900726 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 3.92261024 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.92166467 |
| 64 | amine catabolic process (GO:0009310) | 3.92166467 |
| 65 | positive regulation of fatty acid oxidation (GO:0046321) | 3.88559429 |
| 66 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88105097 |
| 67 | arginine metabolic process (GO:0006525) | 3.85300503 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83644027 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.83488048 |
| 70 | glucuronate metabolic process (GO:0019585) | 3.82970719 |
| 71 | uronic acid metabolic process (GO:0006063) | 3.82970719 |
| 72 | glycine metabolic process (GO:0006544) | 3.82138455 |
| 73 | glutamate metabolic process (GO:0006536) | 3.81906337 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.81657195 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 3.80826817 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 3.80086698 |
| 77 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.79920799 |
| 78 | fibrinolysis (GO:0042730) | 3.75075724 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.74083918 |
| 80 | * flavonoid metabolic process (GO:0009812) | 3.70629812 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.69333047 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.68600735 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.67831009 |
| 84 | organic acid catabolic process (GO:0016054) | 3.67831009 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.67752514 |
| 86 | drug metabolic process (GO:0017144) | 3.67715405 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.66798059 |
| 88 | cholesterol homeostasis (GO:0042632) | 3.65683596 |
| 89 | protein activation cascade (GO:0072376) | 3.65550325 |
| 90 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.64403660 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63802942 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63802942 |
| 93 | cofactor catabolic process (GO:0051187) | 3.62147688 |
| 94 | sterol homeostasis (GO:0055092) | 3.58402624 |
| 95 | heme transport (GO:0015886) | 3.57113427 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.56724634 |
| 97 | cellular anion homeostasis (GO:0030002) | 3.55818540 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55026114 |
| 99 | complement activation (GO:0006956) | 3.55011661 |
| 100 | response to nitrosative stress (GO:0051409) | 3.54605946 |
| 101 | fatty acid oxidation (GO:0019395) | 3.54242798 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.53203357 |
| 103 | acute-phase response (GO:0006953) | 3.53017172 |
| 104 | * sulfation (GO:0051923) | 3.52310234 |
| 105 | exogenous drug catabolic process (GO:0042738) | 3.51903250 |
| 106 | monocarboxylic acid catabolic process (GO:0072329) | 3.51533297 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.50626992 |
| 108 | opsonization (GO:0008228) | 3.45317589 |
| 109 | epoxygenase P450 pathway (GO:0019373) | 3.31359939 |
| 110 | cellular response to exogenous dsRNA (GO:0071360) | 3.23398964 |
| 111 | interferon-gamma secretion (GO:0072643) | 3.05642598 |
| 112 | positive regulation of mast cell activation (GO:0033005) | 3.05216434 |
| 113 | regulation of germinal center formation (GO:0002634) | 3.01590709 |
| 114 | regulation of cholesterol storage (GO:0010885) | 2.99331709 |
| 115 | diacylglycerol metabolic process (GO:0046339) | 2.95429401 |
| 116 | behavioral response to nicotine (GO:0035095) | 2.94751916 |
| 117 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.91889280 |
| 118 | alkaloid metabolic process (GO:0009820) | 2.89572997 |
| 119 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.88329719 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88078361 |
| 121 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.86625220 |
| 122 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.82964780 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.82683539 |
| 124 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81922986 |
| 125 | regulation of mast cell activation (GO:0033003) | 2.81101755 |
| 126 | NAD biosynthetic process (GO:0009435) | 2.80699834 |
| 127 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.79216812 |
| 128 | regulation of glomerulus development (GO:0090192) | 2.78793362 |
| 129 | transepithelial transport (GO:0070633) | 2.75671689 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 2.73969464 |
| 131 | lipoprotein transport (GO:0042953) | 2.71978912 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.71340390 |
| 133 | positive regulation of digestive system process (GO:0060456) | 2.71133853 |
| 134 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.70098820 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.69993180 |
| 136 | regulation of sequestering of triglyceride (GO:0010889) | 2.68999729 |
| 137 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67741413 |
| 138 | positive regulation of mast cell degranulation (GO:0043306) | 2.67741413 |
| 139 | cytidine catabolic process (GO:0006216) | 2.64931712 |
| 140 | cytidine deamination (GO:0009972) | 2.64931712 |
| 141 | cytidine metabolic process (GO:0046087) | 2.64931712 |
| 142 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64877143 |
| 143 | modulation by symbiont of host defense response (GO:0052031) | 2.64877143 |
| 144 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64877143 |
| 145 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64877143 |
| 146 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64877143 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.64877143 |
| 148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63946680 |
| 149 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61990725 |
| 150 | negative regulation of cell killing (GO:0031342) | 2.61990725 |
| 151 | * purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.61097649 |
| 152 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.61097649 |
| 153 | DNA deamination (GO:0045006) | 2.60783478 |
| 154 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60129168 |
| 155 | angiotensin maturation (GO:0002003) | 2.57803823 |
| 156 | vitamin biosynthetic process (GO:0009110) | 2.57669933 |
| 157 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.54655169 |
| 158 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.54173836 |
| 159 | negative regulation of platelet activation (GO:0010544) | 2.51820006 |
| 160 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.51445373 |
| 161 | cell proliferation in forebrain (GO:0021846) | 2.50660166 |
| 162 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.49787927 |
| 163 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.48054965 |
| 164 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47297116 |
| 165 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.46462766 |
| 166 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.46462766 |
| 167 | ethanol metabolic process (GO:0006067) | 2.45311154 |
| 168 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.45271943 |
| 169 | positive regulation of fatty acid transport (GO:2000193) | 2.44337984 |
| 170 | intestinal absorption (GO:0050892) | 2.43827313 |
| 171 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.42342638 |
| 172 | regulation of mast cell degranulation (GO:0043304) | 2.41930496 |
| 173 | detection of bacterium (GO:0016045) | 2.41402816 |
| 174 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.40309073 |
| 175 | detection of other organism (GO:0098543) | 2.40204818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.86380426 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.71210153 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.49016680 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10719102 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.72154112 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.63595360 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10435366 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89789828 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.65532900 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.59971611 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28975129 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.60248255 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21624031 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13885133 |
| 15 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0787821 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99642587 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.86629564 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82180025 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81198755 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78359437 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65730229 |
| 22 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.61606555 |
| 23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60742293 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60371793 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.56318141 |
| 26 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55231004 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53520662 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52927032 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48742978 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47302861 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45214364 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43519912 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42602178 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41091459 |
| 35 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.40452872 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33077433 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31192192 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31000853 |
| 39 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29942549 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27369452 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26664241 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.26388445 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.25896288 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24995620 |
| 45 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24717034 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24715370 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23824427 |
| 48 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.23439622 |
| 49 | ERA_21632823_ChIP-Seq_H3396_Human | 1.23024782 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22237202 |
| 51 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.19192167 |
| 52 | P300_27268052_Chip-Seq_Bcells_Human | 1.17896779 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14900423 |
| 54 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14747026 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14365563 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13445747 |
| 57 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11016049 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09567679 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09327087 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08892122 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08719586 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08551770 |
| 63 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.08489109 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.08258589 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07596955 |
| 66 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05808886 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04403351 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04301461 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03998265 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03936424 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03306333 |
| 72 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02640908 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02443619 |
| 74 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02090290 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01972127 |
| 76 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99535707 |
| 77 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97403462 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97068067 |
| 79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96457899 |
| 80 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96439202 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95805974 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95568792 |
| 83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95534842 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95517568 |
| 85 | MAF_26560356_Chip-Seq_TH1_Human | 0.94526508 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94369120 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93968898 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 0.93305311 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93278362 |
| 90 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92872453 |
| 91 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91887250 |
| 92 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91459271 |
| 93 | * MAF_26560356_Chip-Seq_TH2_Human | 0.90360391 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90173963 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89904463 |
| 96 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89577395 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89417114 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89229933 |
| 99 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88603189 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83803109 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82920088 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82877356 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82544108 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81430629 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80415850 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79885433 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79871304 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79551734 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77452141 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73640436 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73374531 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73058716 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71158311 |
| 114 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70433942 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70059107 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69502010 |
| 117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.68318899 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67925039 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66910071 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66079430 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65782013 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65625143 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65447071 |
| 124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62689953 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62444684 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62183640 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62092027 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61491740 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61491740 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.60884774 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59796061 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58625189 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.56077860 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54810521 |
| 135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54745295 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54464470 |
| 137 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54397099 |
| 138 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54217472 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52572419 |
| 140 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.52391299 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50437134 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50255552 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50074352 |
| 144 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.49297662 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49034477 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47972872 |
| 147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46706574 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46328719 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46186231 |
| 150 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45893137 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45198487 |
| 152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.45101603 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44291260 |
| 154 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.44187566 |
| 155 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.44142785 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43855984 |
| 157 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.43617629 |
| 158 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43170232 |
| 159 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43038486 |
| 160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.42780981 |
| 161 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42777428 |
| 162 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42216975 |
| 163 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.41921141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.78119577 |
| 2 | MP0005360_urolithiasis | 7.01029591 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.14933471 |
| 4 | MP0005365_abnormal_bile_salt | 5.88129663 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13706209 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.91993777 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.61091738 |
| 8 | MP0003252_abnormal_bile_duct | 3.60678484 |
| 9 | MP0009840_abnormal_foam_cell | 3.23782979 |
| 10 | MP0005083_abnormal_biliary_tract | 2.97677290 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.71508734 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.59604023 |
| 13 | MP0005332_abnormal_amino_acid | 2.58741384 |
| 14 | MP0003195_calcinosis | 2.43680445 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.16151471 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.12219442 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11914950 |
| 18 | MP0000609_abnormal_liver_physiology | 2.10230770 |
| 19 | MP0002132_abnormal_respiratory_system | 2.08393587 |
| 20 | MP0003868_abnormal_feces_composition | 2.04118945 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.00468402 |
| 22 | MP0005671_abnormal_response_to | 1.97005552 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.95943570 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.93817606 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.85045802 |
| 26 | MP0001800_abnormal_humoral_immune | 1.81298926 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.77538689 |
| 28 | MP0005387_immune_system_phenotype | 1.77144341 |
| 29 | MP0001790_abnormal_immune_system | 1.77144341 |
| 30 | MP0002419_abnormal_innate_immunity | 1.76220567 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.65748202 |
| 32 | MP0001764_abnormal_homeostasis | 1.65153528 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.65054903 |
| 34 | MP0002160_abnormal_reproductive_system | 1.62315640 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61522641 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.59871351 |
| 37 | MP0009697_abnormal_copulation | 1.59243408 |
| 38 | MP0005670_abnormal_white_adipose | 1.56496490 |
| 39 | MP0002723_abnormal_immune_serum | 1.51183364 |
| 40 | MP0003879_abnormal_hair_cell | 1.49546068 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.48445111 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.47422122 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.44173918 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.39383995 |
| 45 | MP0003186_abnormal_redox_activity | 1.35935077 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.35062119 |
| 47 | MP0005451_abnormal_body_composition | 1.33624096 |
| 48 | MP0001819_abnormal_immune_cell | 1.33347749 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.33000638 |
| 50 | MP0003303_peritoneal_inflammation | 1.31967248 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.26703743 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.24261093 |
| 53 | MP0003011_delayed_dark_adaptation | 1.23240040 |
| 54 | MP0000598_abnormal_liver_morphology | 1.17683655 |
| 55 | MP0003866_abnormal_defecation | 1.17144226 |
| 56 | MP0003724_increased_susceptibility_to | 1.16651606 |
| 57 | MP0009764_decreased_sensitivity_to | 1.15721939 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.14594573 |
| 59 | MP0005389_reproductive_system_phenotype | 1.12910271 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.12027531 |
| 61 | MP0004130_abnormal_muscle_cell | 1.11358920 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.10975417 |
| 63 | MP0005647_abnormal_sex_gland | 1.10787554 |
| 64 | MP0009763_increased_sensitivity_to | 1.07943437 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.06346557 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.03473536 |
| 67 | MP0004134_abnormal_chest_morphology | 1.03337829 |
| 68 | MP0002254_reproductive_system_inflammat | 1.02394702 |
| 69 | MP0001873_stomach_inflammation | 0.98977194 |
| 70 | MP0008469_abnormal_protein_level | 0.97789692 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.97472655 |
| 72 | MP0001663_abnormal_digestive_system | 0.94651208 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.93825165 |
| 74 | MP0000716_abnormal_immune_system | 0.92969422 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.92020209 |
| 76 | MP0002405_respiratory_system_inflammati | 0.91481821 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.90748066 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.90455263 |
| 79 | MP0003646_muscle_fatigue | 0.90439078 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.89555976 |
| 81 | MP0000604_amyloidosis | 0.88902453 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.87253008 |
| 83 | MP0005310_abnormal_salivary_gland | 0.86802240 |
| 84 | MP0002971_abnormal_brown_adipose | 0.85408336 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.84264421 |
| 86 | MP0005334_abnormal_fat_pad | 0.84008795 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.83272718 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.83092206 |
| 89 | MP0003690_abnormal_glial_cell | 0.82838947 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.81660612 |
| 91 | MP0001661_extended_life_span | 0.80626262 |
| 92 | MP0002822_catalepsy | 0.78739682 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.75344962 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.74851441 |
| 95 | MP0002398_abnormal_bone_marrow | 0.73246566 |
| 96 | MP0005535_abnormal_body_temperature | 0.70247136 |
| 97 | MP0001968_abnormal_touch/_nociception | 0.70030099 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.69849241 |
| 99 | MP0003878_abnormal_ear_physiology | 0.69849241 |
| 100 | MP0001664_abnormal_digestion | 0.69775637 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.68960454 |
| 102 | MP0001756_abnormal_urination | 0.67673596 |
| 103 | MP0005410_abnormal_fertilization | 0.67248443 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.66719009 |
| 105 | MP0001440_abnormal_grooming_behavior | 0.66079470 |
| 106 | MP0002722_abnormal_immune_system | 0.65376129 |
| 107 | MP0004947_skin_inflammation | 0.65286986 |
| 108 | MP0005266_abnormal_metabolism | 0.64795493 |
| 109 | MP0003075_altered_response_to | 0.62688034 |
| 110 | MP0005448_abnormal_energy_balance | 0.59882059 |
| 111 | MP0005408_hypopigmentation | 0.59672338 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.58627019 |
| 113 | MP0003436_decreased_susceptibility_to | 0.57937729 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.56385195 |
| 115 | MP0008873_increased_physiological_sensi | 0.55073574 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.54673888 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.52222825 |
| 118 | MP0000249_abnormal_blood_vessel | 0.52019846 |
| 119 | MP0009115_abnormal_fat_cell | 0.49816407 |
| 120 | MP0009785_altered_susceptibility_to | 0.49127059 |
| 121 | MP0008874_decreased_physiological_sensi | 0.48932779 |
| 122 | MP0003300_gastrointestinal_ulcer | 0.48768048 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.47255666 |
| 124 | MP0005166_decreased_susceptibility_to | 0.46977344 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.45716567 |
| 126 | MP0003953_abnormal_hormone_level | 0.43964206 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.43829489 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.43506091 |
| 129 | MP0002796_impaired_skin_barrier | 0.42032611 |
| 130 | MP0004883_abnormal_blood_vessel | 0.41121073 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.39731409 |
| 132 | MP0001853_heart_inflammation | 0.39234986 |
| 133 | MP0002928_abnormal_bile_duct | 0.39166911 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.39015294 |
| 135 | MP0005164_abnormal_response_to | 0.38607279 |
| 136 | MP0005025_abnormal_response_to | 0.37886203 |
| 137 | MP0008872_abnormal_physiological_respon | 0.37792983 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.37246136 |
| 139 | MP0004147_increased_porphyrin_level | 0.37210815 |
| 140 | MP0002970_abnormal_white_adipose | 0.37062353 |
| 141 | MP0002060_abnormal_skin_morphology | 0.36639994 |
| 142 | MP0004264_abnormal_extraembryonic_tissu | 0.34929288 |
| 143 | MP0000685_abnormal_immune_system | 0.34657972 |
| 144 | MP0003329_amyloid_beta_deposits | 0.34476549 |
| 145 | MP0005395_other_phenotype | 0.34426907 |
| 146 | MP0009379_abnormal_foot_pigmentation | 0.33749131 |
| 147 | MP0009053_abnormal_anal_canal | 0.32786092 |
| 148 | MP0006082_CNS_inflammation | 0.32573604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.97748731 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.93636374 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.70901361 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.33562052 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.08381115 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.02162333 |
| 7 | Xanthomatosis (HP:0000991) | 6.01369444 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.58588770 |
| 9 | Complement deficiency (HP:0004431) | 5.11316294 |
| 10 | Joint hemorrhage (HP:0005261) | 4.79542377 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.76270810 |
| 12 | Hyperammonemia (HP:0001987) | 4.60540184 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45504171 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 4.33249473 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.25344338 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24276391 |
| 17 | Epidermoid cyst (HP:0200040) | 4.20127219 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08971424 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07764743 |
| 20 | Ketosis (HP:0001946) | 4.06564698 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04699586 |
| 22 | Hyperglycinemia (HP:0002154) | 4.04580341 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.97785214 |
| 24 | Hyperglycinuria (HP:0003108) | 3.77438505 |
| 25 | Fat malabsorption (HP:0002630) | 3.72877626 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72877525 |
| 27 | Abnormality of complement system (HP:0005339) | 3.72280952 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70007796 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.70007796 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.64523880 |
| 31 | Pendular nystagmus (HP:0012043) | 3.47095823 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45781149 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43523165 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.30366028 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27549106 |
| 36 | Spontaneous abortion (HP:0005268) | 3.22489292 |
| 37 | Congenital sensorineural hearing impairment (HP:0008527) | 3.19200436 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.15190247 |
| 39 | Genetic anticipation (HP:0003743) | 3.14898377 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04748071 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.04748071 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.96285988 |
| 43 | Short 1st metacarpal (HP:0010034) | 2.94294280 |
| 44 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.94294280 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94216593 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.94130285 |
| 47 | Confusion (HP:0001289) | 2.91442659 |
| 48 | Ketoacidosis (HP:0001993) | 2.84536862 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.84297523 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.83038853 |
| 51 | Metabolic acidosis (HP:0001942) | 2.81607971 |
| 52 | Steatorrhea (HP:0002570) | 2.79042495 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.78992013 |
| 54 | Myositis (HP:0100614) | 2.74280434 |
| 55 | Abnormality of the 1st metacarpal (HP:0010009) | 2.73377444 |
| 56 | Myocardial infarction (HP:0001658) | 2.73331234 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.69563307 |
| 58 | Lethargy (HP:0001254) | 2.68032248 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.67632700 |
| 60 | Glomerulonephritis (HP:0000099) | 2.65398039 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.62201709 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.60847004 |
| 63 | Acanthocytosis (HP:0001927) | 2.57667363 |
| 64 | Vascular calcification (HP:0004934) | 2.55975467 |
| 65 | Severe visual impairment (HP:0001141) | 2.55689138 |
| 66 | Skin nodule (HP:0200036) | 2.54474559 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.53706163 |
| 68 | Cerebral edema (HP:0002181) | 2.53342498 |
| 69 | Orchitis (HP:0100796) | 2.51908829 |
| 70 | Hemiplegia (HP:0002301) | 2.50514219 |
| 71 | Amyloidosis (HP:0011034) | 2.49498208 |
| 72 | Esophageal varix (HP:0002040) | 2.48507344 |
| 73 | Decreased central vision (HP:0007663) | 2.46678312 |
| 74 | Decreased circulating renin level (HP:0003351) | 2.46642948 |
| 75 | Menorrhagia (HP:0000132) | 2.45325890 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.44432285 |
| 77 | Optic neuritis (HP:0100653) | 2.41457846 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.41457846 |
| 79 | Visual hallucinations (HP:0002367) | 2.41395958 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.40509882 |
| 81 | Conjunctival hamartoma (HP:0100780) | 2.39634615 |
| 82 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39255474 |
| 83 | Recurrent fungal infections (HP:0002841) | 2.39127468 |
| 84 | Gingival bleeding (HP:0000225) | 2.38861352 |
| 85 | Agitation (HP:0000713) | 2.34479906 |
| 86 | Progressive cerebellar ataxia (HP:0002073) | 2.33950582 |
| 87 | Stomatitis (HP:0010280) | 2.31330382 |
| 88 | Neonatal onset (HP:0003623) | 2.27873301 |
| 89 | Bone cyst (HP:0012062) | 2.27832260 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.27749506 |
| 91 | Pigmentary retinal degeneration (HP:0001146) | 2.27455360 |
| 92 | Short phalanx of the thumb (HP:0009660) | 2.27013534 |
| 93 | Pancreatitis (HP:0001733) | 2.25492515 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.23365726 |
| 95 | Porencephaly (HP:0002132) | 2.23199695 |
| 96 | Gout (HP:0001997) | 2.22890554 |
| 97 | Spastic diplegia (HP:0001264) | 2.22463441 |
| 98 | Late onset (HP:0003584) | 2.21476609 |
| 99 | Irritability (HP:0000737) | 2.21062698 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.20995334 |
| 101 | Alkalosis (HP:0001948) | 2.19880509 |
| 102 | Abnormal gallbladder morphology (HP:0012437) | 2.18912476 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17606443 |
| 104 | Cholelithiasis (HP:0001081) | 2.15899969 |
| 105 | Thrombophlebitis (HP:0004418) | 2.15332710 |
| 106 | Vomiting (HP:0002013) | 2.14249610 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.13389635 |
| 108 | Abnormal gallbladder physiology (HP:0012438) | 2.12963432 |
| 109 | Cholecystitis (HP:0001082) | 2.12963432 |
| 110 | Mitral stenosis (HP:0001718) | 2.12608095 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 2.10268425 |
| 112 | Hypertriglyceridemia (HP:0002155) | 2.09705303 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08912857 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08912857 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08912857 |
| 116 | Congenital stationary night blindness (HP:0007642) | 2.06602990 |
| 117 | Mediastinal lymphadenopathy (HP:0100721) | 2.06256676 |
| 118 | Hypochromic anemia (HP:0001931) | 2.06054232 |
| 119 | Hemorrhage of the eye (HP:0011885) | 2.04809474 |
| 120 | Malnutrition (HP:0004395) | 2.04426838 |
| 121 | Abnormality of B cell number (HP:0010975) | 2.03801507 |
| 122 | Abnormality of macrophages (HP:0004311) | 2.03055191 |
| 123 | Short femoral neck (HP:0100864) | 2.01627336 |
| 124 | Abnormality of binocular vision (HP:0011514) | 2.01615527 |
| 125 | Diplopia (HP:0000651) | 2.01615527 |
| 126 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.00837380 |
| 127 | Abnormality of the nasal septum (HP:0000419) | 1.99924449 |
| 128 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97882018 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.97690496 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 1.97690496 |
| 131 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97688391 |
| 132 | Petechiae (HP:0000967) | 1.97187550 |
| 133 | Abnormality of DNA repair (HP:0003254) | 1.97117124 |
| 134 | Meningitis (HP:0001287) | 1.97057737 |
| 135 | Opisthotonus (HP:0002179) | 1.96835940 |
| 136 | Abnormal cartilage morphology (HP:0002763) | 1.96825135 |
| 137 | Nephritis (HP:0000123) | 1.96698742 |
| 138 | Ventricular fibrillation (HP:0001663) | 1.94468358 |
| 139 | Methylmalonic acidemia (HP:0002912) | 1.93863781 |
| 140 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.93767710 |
| 141 | Absent thumb (HP:0009777) | 1.93634109 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.93537593 |
| 143 | Encephalitis (HP:0002383) | 1.91517960 |
| 144 | Chorioretinal atrophy (HP:0000533) | 1.91482236 |
| 145 | Brushfield spots (HP:0001088) | 1.91442214 |
| 146 | Hypoplasia of the thymus (HP:0000778) | 1.91047569 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90970019 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89969903 |
| 149 | Enlarged kidneys (HP:0000105) | 1.89834832 |
| 150 | Attenuation of retinal blood vessels (HP:0007843) | 1.89461488 |
| 151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89140547 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.87883001 |
| 153 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87883001 |
| 154 | Anorexia (HP:0002039) | 1.86911531 |
| 155 | Poikilocytosis (HP:0004447) | 1.86554158 |
| 156 | Recurrent skin infections (HP:0001581) | 1.85498782 |
| 157 | Carpal bone hypoplasia (HP:0001498) | 1.84919837 |
| 158 | Hamartoma of the eye (HP:0010568) | 1.84769817 |
| 159 | Purpura (HP:0000979) | 1.84308925 |
| 160 | Pustule (HP:0200039) | 1.82880943 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82641884 |
| 162 | Hemoptysis (HP:0002105) | 1.82634432 |
| 163 | Abnormality of vitamin metabolism (HP:0100508) | 1.82566600 |
| 164 | Pancreatic cysts (HP:0001737) | 1.81804405 |
| 165 | Abnormality of the costochondral junction (HP:0000919) | 1.81448168 |
| 166 | Pulmonary infiltrates (HP:0002113) | 1.80640297 |
| 167 | Elevated hepatic transaminases (HP:0002910) | 1.80392670 |
| 168 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79708079 |
| 169 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79708079 |
| 170 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79708079 |
| 171 | Abnormality of the gallbladder (HP:0005264) | 1.79451689 |
| 172 | Rickets (HP:0002748) | 1.79439593 |
| 173 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78887142 |
| 174 | Obstructive lung disease (HP:0006536) | 1.78887142 |
| 175 | Leukocytosis (HP:0001974) | 1.78778899 |
| 176 | Renal cortical cysts (HP:0000803) | 1.78769983 |
| 177 | Hyperuricemia (HP:0002149) | 1.78683459 |
| 178 | Increased purine levels (HP:0004368) | 1.78683459 |
| 179 | Symptomatic seizures (HP:0011145) | 1.78380121 |
| 180 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77858502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.37125798 |
| 2 | ERN1 | 4.83136357 |
| 3 | FGFR4 | 3.55871398 |
| 4 | SIK1 | 3.46008695 |
| 5 | ACVR1B | 3.03203222 |
| 6 | ADRBK2 | 2.82351524 |
| 7 | RIPK4 | 2.78365467 |
| 8 | MST1R | 2.66115291 |
| 9 | TIE1 | 2.63505415 |
| 10 | TAOK3 | 2.39059301 |
| 11 | INSRR | 2.30160218 |
| 12 | PKN2 | 2.21584503 |
| 13 | PRKD2 | 2.21383832 |
| 14 | KDR | 2.20407078 |
| 15 | TGFBR2 | 2.15957460 |
| 16 | TRIB3 | 1.94336111 |
| 17 | TLK1 | 1.86522270 |
| 18 | TNK2 | 1.85705568 |
| 19 | CAMK1D | 1.74431548 |
| 20 | NEK9 | 1.74156922 |
| 21 | ERBB4 | 1.71060657 |
| 22 | PIK3CA | 1.68977604 |
| 23 | TXK | 1.66630473 |
| 24 | TBK1 | 1.64563908 |
| 25 | SYK | 1.64501584 |
| 26 | TYK2 | 1.62811655 |
| 27 | MAP2K4 | 1.61915703 |
| 28 | PIK3CG | 1.53817461 |
| 29 | FRK | 1.49028944 |
| 30 | FLT3 | 1.45386906 |
| 31 | MAP2K3 | 1.40239875 |
| 32 | MAP3K7 | 1.39642829 |
| 33 | MAPK11 | 1.39533703 |
| 34 | FES | 1.38404759 |
| 35 | PTK6 | 1.37389803 |
| 36 | MUSK | 1.36863407 |
| 37 | ABL2 | 1.24588157 |
| 38 | EPHB1 | 1.24131221 |
| 39 | IRAK4 | 1.22718369 |
| 40 | MYLK | 1.19700320 |
| 41 | JAK2 | 1.18059886 |
| 42 | RIPK1 | 1.17242096 |
| 43 | TGFBR1 | 1.17100376 |
| 44 | PINK1 | 1.14717204 |
| 45 | ITK | 1.13584951 |
| 46 | PRKAA2 | 1.08779883 |
| 47 | IKBKE | 1.07500392 |
| 48 | GRK7 | 1.05343623 |
| 49 | MAP2K6 | 1.03706397 |
| 50 | MAP2K2 | 1.02940404 |
| 51 | MAP3K14 | 1.00324513 |
| 52 | CSK | 0.99813978 |
| 53 | JAK1 | 0.97987598 |
| 54 | DAPK2 | 0.97490879 |
| 55 | NLK | 0.96971838 |
| 56 | MAPK12 | 0.95869438 |
| 57 | HCK | 0.95106815 |
| 58 | EPHA3 | 0.93964703 |
| 59 | LCK | 0.90507567 |
| 60 | GRK5 | 0.89165334 |
| 61 | MATK | 0.87199077 |
| 62 | TAOK1 | 0.87034386 |
| 63 | MAPK4 | 0.86540112 |
| 64 | CAMK1G | 0.84205020 |
| 65 | BMPR1B | 0.84007377 |
| 66 | PRKG2 | 0.83719824 |
| 67 | LATS1 | 0.81977701 |
| 68 | AKT3 | 0.81054088 |
| 69 | GRK1 | 0.77326949 |
| 70 | NUAK1 | 0.74381359 |
| 71 | MET | 0.72568405 |
| 72 | GRK6 | 0.70059910 |
| 73 | WNK4 | 0.68891310 |
| 74 | MAP4K1 | 0.68224084 |
| 75 | RPS6KA6 | 0.67745978 |
| 76 | HIPK2 | 0.67453802 |
| 77 | PRKACG | 0.67088764 |
| 78 | MAP3K11 | 0.65498041 |
| 79 | PDPK1 | 0.65265997 |
| 80 | CDK6 | 0.64829384 |
| 81 | ZAK | 0.64792788 |
| 82 | MAP2K1 | 0.64773769 |
| 83 | MAPKAPK3 | 0.64056972 |
| 84 | MAPK15 | 0.63874683 |
| 85 | CAMKK2 | 0.63423304 |
| 86 | ADRBK1 | 0.63016546 |
| 87 | FGFR2 | 0.62638558 |
| 88 | CSF1R | 0.62185248 |
| 89 | MAP3K1 | 0.59450567 |
| 90 | MAP4K2 | 0.59157302 |
| 91 | ERBB2 | 0.58764821 |
| 92 | IRAK3 | 0.58516023 |
| 93 | MAP3K3 | 0.57974940 |
| 94 | FGR | 0.57489743 |
| 95 | PDK1 | 0.57245200 |
| 96 | SGK2 | 0.56646200 |
| 97 | EPHB2 | 0.56074790 |
| 98 | PRKCZ | 0.54395198 |
| 99 | IGF1R | 0.53294103 |
| 100 | CAMK2G | 0.52406016 |
| 101 | IRAK1 | 0.52283148 |
| 102 | FGFR3 | 0.52142586 |
| 103 | MAPK7 | 0.51444314 |
| 104 | GSK3A | 0.50598723 |
| 105 | JAK3 | 0.49898986 |
| 106 | TNIK | 0.49207580 |
| 107 | MARK3 | 0.48888980 |
| 108 | OXSR1 | 0.48511562 |
| 109 | RPS6KC1 | 0.48466870 |
| 110 | RPS6KL1 | 0.48466870 |
| 111 | SGK223 | 0.48049505 |
| 112 | SGK494 | 0.48049505 |
| 113 | STK11 | 0.47392783 |
| 114 | PTK2B | 0.46118287 |
| 115 | SIK2 | 0.45211136 |
| 116 | MAPK13 | 0.44991394 |
| 117 | PRKAA1 | 0.44955658 |
| 118 | PIM1 | 0.44302434 |
| 119 | PRKD1 | 0.42781609 |
| 120 | CSNK1G1 | 0.42307074 |
| 121 | CDK9 | 0.41737636 |
| 122 | FYN | 0.41593566 |
| 123 | KIT | 0.40983213 |
| 124 | PDGFRA | 0.40869275 |
| 125 | DAPK3 | 0.40767671 |
| 126 | SGK1 | 0.40132966 |
| 127 | IKBKB | 0.39933997 |
| 128 | SGK3 | 0.38919537 |
| 129 | NME2 | 0.38854193 |
| 130 | DYRK1B | 0.38103543 |
| 131 | RET | 0.37526098 |
| 132 | TEC | 0.37062327 |
| 133 | MAP3K13 | 0.36342379 |
| 134 | BTK | 0.35668824 |
| 135 | ZAP70 | 0.35547927 |
| 136 | DDR2 | 0.31723491 |
| 137 | BLK | 0.31471304 |
| 138 | EGFR | 0.30967650 |
| 139 | PRKCA | 0.29005179 |
| 140 | MAP3K2 | 0.26991452 |
| 141 | PRKCQ | 0.26799177 |
| 142 | LYN | 0.26176098 |
| 143 | MAPK3 | 0.24074328 |
| 144 | CAMK4 | 0.23530956 |
| 145 | CAMKK1 | 0.23267155 |
| 146 | PTK2 | 0.21239790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15201885 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51580859 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44018952 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01803079 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87290426 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70337698 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59017689 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55565606 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54890836 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54512071 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54349679 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41193129 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34327959 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.27535008 |
| 15 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.26603056 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19385529 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05227627 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04235884 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.02779726 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.01696016 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01086969 |
| 22 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00718341 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00670840 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95086949 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94104801 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89616828 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88857982 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86169628 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83654865 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.82944992 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82266855 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72367821 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70545524 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68624692 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67338162 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61270448 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53094047 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52665950 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.52640688 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51186051 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.50397680 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.47568188 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47455698 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46920730 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40515223 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34702541 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34374889 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33098324 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31511034 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30364116 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29565451 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27171712 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26825320 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.23615597 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15354067 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.14852356 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14558912 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11734644 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11705849 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11091791 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09028739 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08372602 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06554200 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99676256 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98478365 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96945101 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96915692 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95547597 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95494742 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94460404 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85997982 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.84835833 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84386608 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83537292 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80388887 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79012691 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78638626 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78335585 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70838587 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68755630 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67511561 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66729723 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65426562 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.65402580 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62629928 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61223174 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60302318 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59374575 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56699547 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56371667 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55164077 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55104250 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54967039 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50765758 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47886651 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47646737 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47046910 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45817868 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.45255217 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.44919873 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44589792 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.43963329 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40699160 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40531264 |
| 105 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39887390 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39731049 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39557136 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.35151823 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34568904 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.32492368 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32108326 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30369742 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29394115 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28066993 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.26048329 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.24027176 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20078527 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18582916 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08929587 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05213163 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03931947 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03381124 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01214597 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1965239 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1962494 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1940643 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1897257 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1861137 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1775062 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | -0.1674283 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1666130 |
| 132 | Malaria_Homo sapiens_hsa05144 | -0.1653208 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1646162 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1564962 |
| 135 | Pertussis_Homo sapiens_hsa05133 | -0.1482459 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | -0.1271432 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1184116 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0873871 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0629397 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0400392 |
| 141 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0077659 |

